We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Use Device Component in Combo Product Trials, Produce Drug-Level Data
Use Device Component in Combo Product Trials, Produce Drug-Level Data
September 26, 2012
Drugmakers should include the device component of a combination product in the pivotal trial of the drug or biologic or face additional regulatory hurdles later, a top FDA official said.